“…Despite curative intent treatments for LPC/LAPC, rates of recurrence, progression and death remain significant. 26 , 27 , 28 , 29 , 30 Patients with high-risk LPC can have up to a 14-fold increased risk of PC-specific mortality relative to those with low-risk LPC. 31 Combination treatments, e.g.…”